Ex vivo lung perfusion with adenosine A2A receptor agonist allows prolonged cold preservation of lungs donated after cardiac death

J Thorac Cardiovasc Surg. 2016 Feb;151(2):538-45. doi: 10.1016/j.jtcvs.2015.07.075. Epub 2015 Jul 30.

Abstract

Objective: Ex vivo lung perfusion has been successful in the assessment of marginal donor lungs, including donation after cardiac death (DCD) donor lungs. Ex vivo lung perfusion also represents a unique platform for targeted drug delivery. We sought to determine whether ischemia-reperfusion injury would be decreased after transplantation of DCD donor lungs subjected to prolonged cold preservation and treated with an adenosine A2A receptor agonist during ex vivo lung perfusion.

Methods: Porcine DCD donor lungs were preserved at 4°C for 12 hours and underwent ex vivo lung perfusion for 4 hours. Left lungs were then transplanted and reperfused for 4 hours. Three groups (n = 4/group) were randomized according to treatment with the adenosine A2A receptor agonist ATL-1223 or the dimethyl sulfoxide vehicle: Infusion of dimethyl sulfoxide during ex vivo lung perfusion and reperfusion (DMSO), infusion of ATL-1223 during ex vivo lung perfusion and dimethyl sulfoxide during reperfusion (ATL-E), and infusion of ATL-1223 during ex vivo lung perfusion and reperfusion (ATL-E/R). Final Pao2/Fio2 ratios (arterial oxygen partial pressure/fraction of inspired oxygen) were determined from samples obtained from the left superior and inferior pulmonary veins.

Results: Final Pao2/Fio2 ratios in the ATL-E/R group (430.1 ± 26.4 mm Hg) were similar to final Pao2/Fio2 ratios in the ATL-E group (413.6 ± 18.8 mm Hg), but both treated groups had significantly higher final Pao2/Fio2 ratios compared with the dimethyl sulfoxide group (84.8 ± 17.7 mm Hg). Low oxygenation gradients during ex vivo lung perfusion did not preclude superior oxygenation capacity during reperfusion.

Conclusions: After prolonged cold preservation, treatment of DCD donor lungs with an adenosine A2A receptor agonist during ex vivo lung perfusion enabled Pao2/Fio2 ratios greater than 400 mm Hg after transplantation in a preclinical porcine model. Pulmonary function during ex vivo lung perfusion was not predictive of outcomes after transplantation.

Keywords: adenosine A2A receptor agonist; donation after cardiac death; ex vivo lung perfusion; lung transplantation; prolonged cold preservation.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Adenosine A2 Receptor Agonists / pharmacology*
  • Animals
  • Cold Temperature*
  • Cytokines / metabolism
  • Female
  • Lung / drug effects*
  • Lung / metabolism
  • Lung / physiopathology
  • Lung / surgery*
  • Lung Transplantation* / adverse effects
  • Male
  • Models, Animal
  • Organ Preservation Solutions / pharmacology*
  • Perfusion
  • Pulmonary Edema / etiology
  • Pulmonary Edema / metabolism
  • Pulmonary Edema / prevention & control
  • Receptor, Adenosine A2A / drug effects*
  • Receptor, Adenosine A2A / metabolism
  • Reperfusion Injury / etiology
  • Reperfusion Injury / metabolism
  • Reperfusion Injury / pathology
  • Reperfusion Injury / physiopathology
  • Reperfusion Injury / prevention & control*
  • Sus scrofa
  • Time Factors
  • Tissue Preservation / methods*
  • Tissue and Organ Harvesting

Substances

  • Adenosine A2 Receptor Agonists
  • Cytokines
  • Organ Preservation Solutions
  • Receptor, Adenosine A2A